Hyperimmune Globulins Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 54095 | Published Date: Oct 2024 | No. of Page: 103 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL HYPERIMMUNE GLOBULINS INDUSTRY
    2.1 Summary about Hyperimmune Globulins Industry
    2.2 Hyperimmune Globulins Market Trends
        2.2.1 Hyperimmune Globulins Production & Consumption Trends
        2.2.2 Hyperimmune Globulins Demand Structure Trends
    2.3 Hyperimmune Globulins Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Hepatitis B Immunoglobulins
        4.2.2 Rabies Immunoglobulins
        4.2.3 Tetanus Immunoglobulins
        4.2.4 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Government Institutions
        4.3.2 Private Sector
        4.3.3 Others
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Hepatitis B Immunoglobulins
        5.2.2 Rabies Immunoglobulins
        5.2.3 Tetanus Immunoglobulins
        5.2.4 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Government Institutions
        5.3.2 Private Sector
        5.3.3 Others
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Hepatitis B Immunoglobulins
        6.2.2 Rabies Immunoglobulins
        6.2.3 Tetanus Immunoglobulins
        6.2.4 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Government Institutions
        6.3.2 Private Sector
        6.3.3 Others
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Hepatitis B Immunoglobulins
        7.2.2 Rabies Immunoglobulins
        7.2.3 Tetanus Immunoglobulins
        7.2.4 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Government Institutions
        7.3.2 Private Sector
        7.3.3 Others
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Hepatitis B Immunoglobulins
        8.2.2 Rabies Immunoglobulins
        8.2.3 Tetanus Immunoglobulins
        8.2.4 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Government Institutions
        8.3.2 Private Sector
        8.3.3 Others
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Hepatitis B Immunoglobulins
        9.2.2 Rabies Immunoglobulins
        9.2.3 Tetanus Immunoglobulins
        9.2.4 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Government Institutions
        9.3.2 Private Sector
        9.3.3 Others
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 CSL Behring
        10.1.2 Grifols 
        10.1.3 Biotest
        10.1.4 Kedrion
        10.1.5 CBPO
        10.1.6 Emergent (Cangene)
        10.1.7 Kamada
        10.1.8 CNBG
        10.1.9 Hualan Bio
        10.1.10 Shanghai RAAS
        10.1.11 Sichuan Yuanda Shuyang
        10.1.12 ADMA Biologics
    10.2  Hyperimmune Globulins Sales Date of Major Players (2017-2020e)
        10.2.1 CSL Behring
        10.2.2 Grifols 
        10.2.3 Biotest
        10.2.4 Kedrion
        10.2.5 CBPO
        10.2.6 Emergent (Cangene)
        10.2.7 Kamada
        10.2.8 CNBG
        10.2.9 Hualan Bio
        10.2.10 Shanghai RAAS
        10.2.11 Sichuan Yuanda Shuyang
        10.2.12 ADMA Biologics
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
Table Hyperimmune Globulins Product Type Overview
Table Hyperimmune Globulins Product Type Market Share List
Table Hyperimmune Globulins Product Type of Major Players
Table Brief Introduction of CSL Behring
Table Brief Introduction of Grifols 
Table Brief Introduction of Biotest
Table Brief Introduction of Kedrion
Table Brief Introduction of CBPO
Table Brief Introduction of Emergent (Cangene)
Table Brief Introduction of Kamada
Table Brief Introduction of CNBG
Table Brief Introduction of Hualan Bio
Table Brief Introduction of Shanghai RAAS
Table Brief Introduction of Sichuan Yuanda Shuyang
Table Brief Introduction of ADMA Biologics
Table Products & Services of CSL Behring
Table Products & Services of Grifols 
Table Products & Services of Biotest
Table Products & Services of Kedrion
Table Products & Services of CBPO
Table Products & Services of Emergent (Cangene)
Table Products & Services of Kamada
Table Products & Services of CNBG
Table Products & Services of Hualan Bio
Table Products & Services of Shanghai RAAS
Table Products & Services of Sichuan Yuanda Shuyang
Table Products & Services of ADMA Biologics
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Hyperimmune Globulins Market Forecast (Million USD) by Region 2021f-2026f
Table Global Hyperimmune Globulins Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Hyperimmune Globulins Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Hyperimmune Globulins Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Hyperimmune Globulins Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hyperimmune Globulins Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hyperimmune Globulins Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hyperimmune Globulins Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hyperimmune Globulins Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Hyperimmune Globulins Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Hyperimmune Globulins Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis B Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Tetanus Immunoglobulins Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Government Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Private Sector Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hyperimmune Globulins Sales Revenue (Million USD) of CSL Behring 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Grifols  2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Biotest 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Kedrion 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of CBPO 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Emergent (Cangene) 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Kamada 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of CNBG 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Hualan Bio 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Shanghai RAAS 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of Sichuan Yuanda Shuyang 2017-2020e
Figure Hyperimmune Globulins Sales Revenue (Million USD) of ADMA Biologics 2017-2020e
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Hyperimmune Globulins Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hyperimmune Globulins Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hyperimmune Globulins Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

IC Card Market

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope:  ... Read More